Scapular PNF Versus Shoulder Strengthening Exercises in Patients With Lateral Epicondylitis.
Launched by MAHMOUD ESSAM ABU ELFETOUH GHALLAB · Jul 9, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of exercises to see which one helps patients with lateral epicondylitis, commonly known as "tennis elbow," the most. The study will compare scapular proprioceptive neuromuscular facilitation (a specialized type of movement training) with traditional shoulder and scapular strengthening exercises. Researchers want to find out which method is better for reducing pain, improving hand strength, and helping people return to their daily activities.
To take part in this study, participants need to be between 20 and 50 years old and have been experiencing chronic lateral epicondylitis for over three months. The trial will include both men and women, but people who have recently received physical therapy, corticosteroid injections, or have certain health issues will not be eligible. Throughout the trial, participants will be asked to avoid activities that could worsen their symptoms, like lifting or gripping heavy objects. If you think you might qualify and are interested in helping improve treatment for tennis elbow, this could be a great opportunity!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients will be included if they have the following criteria:
- • Fifty-two male and female subjects.
- • Patients complaining of chronic lateral epicondylitis (more than three months).
- • Age between 20-50.
- Exclusion Criteria:
- * Patients will be excluded if they had any of the following conditions:
- • Received physiotherapy in last 3 months.
- • Received corticosteroids injection in lateral epicondyle in last 3 months.
- • Receiving anti-inflammatories medications on regular basis.
- • Had neurologic problems in shoulder, neck and thoracic regions.
- • Had history of rheumatic disease.
- • Had cooperation difficulties due to cognitive disorders. All Patients will be instructed to keep away from activities that aggravate the symptoms such as grasping, lifting, knitting and using a screwdriver during the treatment period.
About Mahmoud Essam Abu Elfetouh Ghallab
Mahmoud Essam Abu Elfetouh Ghallab is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a background in clinical pharmacology and extensive experience in trial management, Ghallab oversees the design, execution, and monitoring of clinical studies, ensuring adherence to regulatory standards and ethical guidelines. His collaborative approach fosters strong partnerships with healthcare professionals and research institutions, facilitating innovative solutions in drug development and therapeutic interventions. Through meticulous oversight and a focus on quality, Ghallab aims to contribute to the advancement of healthcare and the discovery of new treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported